title: Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.
authors.forename: K E
authors.initials: KE
authors.lastname: Anderson
authors.forename: A C
authors.initials: AC
authors.lastname: Girdwood
authors.forename: J A
authors.initials: JA
authors.lastname: Wilson
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa